"/> Novus Biologicals™ Peptide bloquant d’anticorps CC… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps CCDC134

Réf. : BL-RE-052561Réf. fabricant : 18240486 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
79879
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77053. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 17 amino acids near the amino terminus of human CCDC134.

Points forts

Source

Synthetic

(Accession #: NP_079097) The CCDC134 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-052561
Réf. fabricant18240486
Gene ID (Entrez)79879
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77053. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gènecoiled-coil domain containing 134, coiled-coil domain-containing protein 134, dJ821D11.3, FLJ22349, MGC21013
Symbole de gène(s)CCDC134
Type de produitCCDC134
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne17 amino acids near the amino terminus of human CCDC134
Une question, une configuration particulière ?
Contactez-nous pour un devis.